1. Home
  2. INDP vs MOVE Comparison

INDP vs MOVE Comparison

Compare INDP & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • MOVE
  • Stock Information
  • Founded
  • INDP 2000
  • MOVE 2018
  • Country
  • INDP United States
  • MOVE United States
  • Employees
  • INDP N/A
  • MOVE N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • INDP Health Care
  • MOVE Health Care
  • Exchange
  • INDP Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • INDP 5.0M
  • MOVE 5.3M
  • IPO Year
  • INDP N/A
  • MOVE 2021
  • Fundamental
  • Price
  • INDP $11.12
  • MOVE $0.70
  • Analyst Decision
  • INDP Strong Buy
  • MOVE Buy
  • Analyst Count
  • INDP 2
  • MOVE 1
  • Target Price
  • INDP $8.50
  • MOVE $30.00
  • AVG Volume (30 Days)
  • INDP 689.8K
  • MOVE 250.0K
  • Earning Date
  • INDP 08-11-2025
  • MOVE 08-13-2025
  • Dividend Yield
  • INDP N/A
  • MOVE N/A
  • EPS Growth
  • INDP N/A
  • MOVE N/A
  • EPS
  • INDP N/A
  • MOVE N/A
  • Revenue
  • INDP N/A
  • MOVE $1,013,000.00
  • Revenue This Year
  • INDP N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • INDP N/A
  • MOVE $96.77
  • P/E Ratio
  • INDP N/A
  • MOVE N/A
  • Revenue Growth
  • INDP N/A
  • MOVE N/A
  • 52 Week Low
  • INDP $7.56
  • MOVE $0.51
  • 52 Week High
  • INDP $67.48
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • INDP 98.13
  • MOVE 47.73
  • Support Level
  • INDP $0.31
  • MOVE $0.61
  • Resistance Level
  • INDP $0.71
  • MOVE $0.85
  • Average True Range (ATR)
  • INDP 0.07
  • MOVE 0.10
  • MACD
  • INDP 0.77
  • MOVE 0.02
  • Stochastic Oscillator
  • INDP 99.09
  • MOVE 43.49

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: